Stay updated on Long-term Safety of Dupilumab in Pediatric AD Clinical Trial

Sign up to get notified when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Publication added to the Publications section: Long-Term Safety and Efficacy of Dupilumab Treatment in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis, Paediatr Drugs, 2026 Apr 2 (Online ahead of print).
    Difference
    0.0%
    Check dated 2026-04-10T08:50:18.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a new publication citation to the Publications section: 'Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis' Am J Clin Dermatol. 2026 Mar 28.
    Difference
    0.0%
    Check dated 2026-04-03T05:20:36.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T19:46:58.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    - Revision label updated from v3.4.1 to v3.4.2. No substantive content changes to the page.
    Difference
    0.0%
    Check dated 2026-02-12T02:14:45.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.4.0 to v3.4.1 with no visible changes to core content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:30:43.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Show glossary added; minor capitalization changes to QC-related labels; and the revision number updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T21:41:41.000Z thumbnail image

Stay in the know with updates to Long-term Safety of Dupilumab in Pediatric AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.